We are live on ! Find out more
DF

DC Funds Portfolio holdings

AUM $1.49M
1-Year Est. Return 18.57%
This Fund
S&P 500
This Quarter Est. Return
-7.34%
1 Year Est. Return
-18.57%
3 Year Est. Return
-38.34%
5 Year Est. Return
-87.14%
10 Year Est. Return
AUM
$25.5M
AUM Growth
+$4.42M
Cap. Flow
+$5.84M
Cap. Flow %
22.94%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
TCRX icon
TScan Therapeutics
TCRX
+$5.84M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOWL icon
1
Werewolf Therapeutics
HOWL
$17.5M
$10.1M 39.69%
589,102
BRNS
2
Barinthus Biotherapeutics
BRNS
$24.5M
$10.1M 39.68%
642,204
TCRX icon
3
TScan Therapeutics
TCRX
$55.3M
$5.25M 20.63%
+630,000
New +$5.84M

Similar funds

DC Funds's Q3 2021 Portfolio in Review

As of Q3 2021, DC Funds held 3 positions worth $25.5M, up 21% from $21.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

DC Funds deployed $5.84M of net new capital in Q3 2021, opening 1 new position. Its largest new stake was TScan Therapeutics: 630,000 shares worth $5.25M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • DC Funds's largest Q3 2021 buy was TScan Therapeutics: 630,000 shares worth $5.25M.
  • DC Funds's ten largest holdings make up 100% of its $25.5M portfolio in Q3 2021.
  • DC Funds opened 1 new position and closed 0 in Q3 2021.
  • DC Funds's portfolio value rose 21% quarter-over-quarter to $25.5M.

Based on DC Funds's 13F filing for Q3 2021, filed 12 Nov 2021.